Skip to content
CompanySight
Company No. 14441022 · Incorporated 25 Oct 2022

Credo Therapies Ltd

Registered name: CREDO THERAPIES LTD

Part of Oxford Science Enterprises PLC group

Credo Therapies Ltd does not publish its revenue or profit. Its accounts to 31 Dec 2024 show net assets of £1.1m and 12 employees.

Credo Therapies Ltd did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Dec 2024 showed net assets of £1.1m and 12 employees. The company is classified under “other human health activities” and is based in Oxford; we hold 2 years of its filed accounts.

Balance sheet onlySection Q · Human health and social workSIC 86900Other human health activities
Status
Active
Location
Oxford, South East
Age
3 yrs · since 2022
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2024

Key figures

Revenue not disclosed

Credo Therapies Ltd’s accounts for the year to 31 Dec 2024 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.

We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.

Employees
12
Net assets
£1.1m

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202331 Dec 2024
DisclosureNo P&LNo P&L
Profit & loss
Revenue (turnover)——
Profit (best available)——
Staff costs£457k—
Employees (average)1012
Ratios
Profit margin——
Balance sheet — indirect signals, not revenue
Cash at bank£2.3m£818k
Net assets£2.5m£1.1m
Fixed assets£51.4k£51.9k
Current assets£2.5m£1.2m
Debtors£226k£355k
Deferred income£18.8k£29k
SourceAccounts · bulk data May 2024FullAccounts · bulk data Sep 2025
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now £1.1m
Cash at bank
—
Now £818k
Headcount
—
Now 12
Deferred income
—
Now £29k
Fixed assets
—
Now £51.9k

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. Oxford Science Enterprises PLCultimate parent50–75%
  2. Credo Therapies Ltdthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (17)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2024, from the Companies House accounts bulk data published Sep 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.